Department for Business and Trade feature

genedrive plc (AIM: GDR), the point of care pharmacogenetic testing company, is pleased to announce that it has been featured in the UK Government Department for Business and Trade ("DBT") publication "UK Genomics Spotlight 2024: Celebrating success and looking ahead"

The document is available at https://eu.eventscloud.com/website/6238/life-sciences/. The report highlights the UK's depth and breadth of expertise for export as world leaders in the field of genomics, as well as opportunities for investing in the UK. It describes the ecosystem which has enabled the delivery of genomic medicine in the UK and expertise in various national initiatives and programmes which are contributing to the genomics landscape of the future.

The DBT has produced the Genomics Spotlight 2024 to showcase the UK's expertise in genomics and latest developments that make the UK a hub for genomics business and investment, and has worked closely with the NHS, including NHS England and all three of the devolved nations, as well as encouraging input from several key organisations and companies in the UK.

The document showcases UK capabilities in genomics, with the aim to promote this sector to markets around the world, to promote UK plc and the healthcare institutions in place. It highlights both the export potential of UK companies, as well as the investment potential across the wider NHS infrastructure and research institutes, being a reminder of the world leading genomics capabilities of the UK, from the NHS Genomic Medicine Service, to world leading institutions and research cohorts, and the ever-expanding innovation of UK small businesses.

Gino Miele, CEO of genedrive plc, said: "We are delighted to be featured in this spotlight document from the UK Department for Business and Trade on UK genomics capabilities. Genedrive are at the forefront of enabling near-patient pharmacogenetic testing in emergency care paradigms and recognition in features such as this ultimately facilitate education, awareness and promotion of our innovative products in both domestic and international markets."